OVERVIEW

Expert Review in Graft Versus Host Disease (GVHD) is organized by prIME Oncology and will be held during Aug 09, 2017 - Aug 09, 2018.

The target audience for this medical event is physicians and registered nurses who comprise the core hematopoietic stem cell transplantation team, as well as community-based oncology physicians and nurses. This CME Conference has been approved for a maximum of 1.75 AMA PRA Category 1 Credits.

Topics:
• Diagnostic criteria for chronic GVHD
• Steroids for chronic GVHD
• Trials for steroid-refractory chronic GVHD
• Supportive care needs for chronic GVHD
• Novel agents being investigated for acute GVHD

Conference Objectives are :
After completion of this educational activity, participants should be able to:
• Explain the pathophysiology of acute GVHD, as well as the more recent understanding of the biology of chronic GVHD
• Evaluate the potential clinical utility of data on diagnostic and prognostic markers of GVHD
• Utilize treatment and management strategies incorporating new targeted therapies for acute and chronic GVHD based on an understanding of the mechanism of action, benefits, risks, dosing, monitoring, and management of the agents

Additional details will be posted as soon as they are available.